First-in-Central-Europe implantation of the self-expandable Pulsta valve in pulmonary position: Short-term results
Polish Heart Journal · 2024
DOI: 10.33963/v.phj.103312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Heart Journal, 2024. Verfasst von Sara Korabiewska-Pluta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Polish-Mother's Memorial Hospital Research Institute, Łódź, Poland. sara.korabiewska@gmail.com. Hauptthemen laut MEDLINE: Pulmonary Valve, Tetralogy of Fallot, Pulmonary Valve Insufficiency, Heart Valve Prosthesis.
Abstract (Originalsprache)
BACKGROUND: Tetralogy of Fallot after complete correction constantly presents potential challenges in pediatric cardiology. In particular, patients with pulmonary regurgitation require ongoing monitoring, reoperation, or catheter intervention during adolescence. The increasing demand for a wide spectrum of sizes and shapes of implantable prostheses led to the development of the self-expanding Pulsta® valve. AIMS: In this study, we evaluated postprocedural outcomes, focusing on pulmonary valve functionality and right ventricular (RV) parameters, using advanced echocardiographic techniques. METHODS: We reviewed five pediatric patients before and over a 6-month follow-up period after the procedure using three-dimensional echocardiography acquisition (3D transthoracic echocardiography), RV global longitudinal strain, and tissue Doppler imaging. RESULTS: All procedures were successful, with good early effects and no complications. Postprocedural assessment of RV diameter and volume showed a statistically significant reduction, and this trend continued during the follow-up period. However, in this cohort, RV ejection fraction, which was initially within the normal range, showed a slight reduction immediately after the procedure, followed by a gradual return to normal values during the follow-up. Similar statistically significant results in RV strain values were observed. CONCLUSION: In the study group, the Pulsta® valve provided good early-term effectiveness and feasibility without adverse events, and the overall mortality rate was 0%, highlighting the potential benefits of this intervention as measured by echocardiographic parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Polish-Mother's Memorial Hospital Research Institute, Łódź, Poland. sara.korabiewska@gmail.com.
- Department of Cardiology, Polish-Mother's Memorial Hospital Research Institute, Łódź, Poland.
- Cardiovascular Interventional Laboratory, The Children's Memorial Health Institute, Warszawa, Poland.
- Department of Pediatric and Adult Congenital Cardiology and Cardiac Surgery, IRCCS Policlinico, San Donato Milanese, Italy.
Zitieren
APA
Korabiewska-Pluta, S., Michalak, K., Młodawska, J., Łubisz, M., Brzezińska-Rajszys, G., Koleśnik, A., Carminati, M., & Moszura, T. (2024). First-in-Central-Europe implantation of the self-expandable Pulsta valve in pulmonary position: Short-term results. Polish Heart Journal. https://doi.org/10.33963/v.phj.103312
Vancouver
Korabiewska-Pluta S, Michalak K, Młodawska J, Łubisz M, Brzezińska-Rajszys G, Koleśnik A, et al. First-in-Central-Europe implantation of the self-expandable Pulsta valve in pulmonary position: Short-term results. Polish Heart Journal. 2024. doi:10.33963/v.phj.103312
BibTeX
@article{KorabiewskaPluta2024,
author = {Korabiewska-Pluta, Sara and Michalak, Krzysztof and Młodawska, Joanna and Łubisz, Monika and Brzezińska-Rajszys, Grażyna and Koleśnik, Adam and Carminati, Mario and Moszura, Tomasz},
title = {First-in-Central-Europe implantation of the self-expandable Pulsta valve in pulmonary position: Short-term results},
journal = {Polish Heart Journal},
year = {2024},
doi = {10.33963/v.phj.103312}
}
EUVIMED